Amgen (AMGN) Receivables - Other (2018 - 2024)
Historic Receivables - Other for Amgen (AMGN) over the last 8 years, with Q4 2024 value amounting to $521.0 million.
- Amgen's Receivables - Other rose 378.49% to $521.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $521.0 million, marking a year-over-year increase of 378.49%. This contributed to the annual value of $521.0 million for FY2024, which is 378.49% up from last year.
- According to the latest figures from Q4 2024, Amgen's Receivables - Other is $521.0 million, which was up 378.49% from $502.0 million recorded in Q4 2023.
- Amgen's Receivables - Other's 5-year high stood at $780.0 million during Q4 2021, with a 5-year trough of $502.0 million in Q4 2023.
- Its 5-year average for Receivables - Other is $617.2 million, with a median of $583.0 million in 2020.
- Its Receivables - Other has fluctuated over the past 5 years, first soared by 3379.07% in 2021, then tumbled by 2828.57% in 2023.
- Amgen's Receivables - Other (Quarter) stood at $583.0 million in 2020, then skyrocketed by 33.79% to $780.0 million in 2021, then fell by 10.26% to $700.0 million in 2022, then decreased by 28.29% to $502.0 million in 2023, then rose by 3.78% to $521.0 million in 2024.
- Its Receivables - Other stands at $521.0 million for Q4 2024, versus $502.0 million for Q4 2023 and $700.0 million for Q4 2022.